粮食不安全和感知到的财务压力与中风中与成本相关的药物不遵守有关
Journal of health care for the poor and underserved
|July 19, 2023
概括
在中风幸存者中,粮食不安全和财务压力是常见的,并且与与成本相关的药物不遵守有关. 这些因素显著增加了中风患者因成本而不能服用处方药的风险.
科学领域:
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
- 老年学是一门学科.
背景情况:
- 与成本相关的药物不服药 (CRN) 是中风幸存者面临的一个重大挑战.
- 了解粮食不安全和财务压力等社会经济因素对CRN的影响对于改善患者的治疗结果至关重要.
研究的目的:
- 调查粮食不安全,感知到的财务压力和成年中风幸存者的CRN之间的联系.
- 确定影响这些关系的人口和临床因素.
主要方法:
- 从2014-2018年国家健康访谈调查中对成年中风幸存者的回顾性分析.
- 在不同年龄组中计算粮食不安全,财务压力和CRN的加权流行率.
- 后勤回归模型评估粮食不安全/金融压力与CRN之间的关联,调整为共变量.
主要成果:
- 在各个年龄组中观察到粮食不安全 (17-38%),财务压力 (43-76%) 和CRN (6-26%) 的高患病率.
- 粮食不安全和财务压力在45-64岁和≥65.65岁的中风幸存者中显著与CRN相关.
- 几率比率表明,在那些经历粮食不安全和财务压力的老年人群中,CRN风险显著增加.
结论:
- 在中风幸存者中,粮食不安全和感知到的财务压力是普遍存在的.
- 这些社会经济因素是该人口中与成本相关的药物不服药的重要预测因素.
- 解决粮食不安全和经济压力的干预措施可能有助于减少CRN,并改善中风幸存者的药物坚持.
相关概念视频
Atherosclerosis IV: Nursing Management
23
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
23
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Drug Therapy
72
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
72
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
465
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465


